Works matching AU Becker, Heiko

Results: 82
    1
    2
    3

    Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 2, p. 527, doi. 10.1002/1878-0261.13116
    By:
    • Waldeck, Silvia;
    • Mitschke, Jan;
    • Wiesemann, Sebastian;
    • Rassner, Michael;
    • Andrieux, Geoffroy;
    • Deuter, Max;
    • Mutter, Jurik;
    • Lüchtenborg, Anne‐Marie;
    • Kottmann, Daniel;
    • Titze, Laurin;
    • Zeisel, Christoph;
    • Jolic, Martina;
    • Philipp, Ulrike;
    • Lassmann, Silke;
    • Bronsert, Peter;
    • Greil, Christine;
    • Rawluk, Justyna;
    • Becker, Heiko;
    • Isbell, Lisa;
    • Müller, Alexandra
    Publication type:
    Article
    4
    5

    The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00715-4
    By:
    • Meier, Ruth;
    • Greve, Gabriele;
    • Zimmer, Dennis;
    • Bresser, Helena;
    • Berberich, Bettina;
    • Langova, Ralitsa;
    • Stomper, Julia;
    • Rubarth, Anne;
    • Feuerbach, Lars;
    • Lipka, Daniel B.;
    • Hey, Joschka;
    • Grüning, Björn;
    • Brors, Benedikt;
    • Duyster, Justus;
    • Plass, Christoph;
    • Becker, Heiko;
    • Lübbert, Michael
    Publication type:
    Article
    6
    7

    European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies.

    Published in:
    HemaSphere, 2025, v. 9, n. 4, p. 1, doi. 10.1002/hem3.70108
    By:
    • Gribben, John G.;
    • Quintanilla‐Martinez, Leticia;
    • Crompton, Simon;
    • Arends, Jann;
    • Bardin, Christophe;
    • Becker, Heiko;
    • Castinetti, Frederic;
    • Csaba, Dégi L.;
    • D'Anastasi, Melvin;
    • Frese, Thomas;
    • Geissler, Jan;
    • Matuzeviciene, Reda;
    • Mayerhoefer, Marius E.;
    • Medeiros, Rui;
    • Morgan, Kate;
    • Narbutas, Šarūnas;
    • Nier, Samantha;
    • Ricardi, Umberto;
    • Arjona, Eugenia Trigoso;
    • Ungan, Mehmet
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.

    Published in:
    Cancers, 2021, v. 13, n. 5, p. 1151, doi. 10.3390/cancers13051151
    By:
    • Hoefflin, Rouven;
    • Lazarou, Adriana;
    • Hess, Maria Elena;
    • Reiser, Meike;
    • Wehrle, Julius;
    • Metzger, Patrick;
    • Frey, Anna Verena;
    • Becker, Heiko;
    • Aumann, Konrad;
    • Berner, Kai;
    • Boeker, Martin;
    • Buettner, Nico;
    • Dierks, Christine;
    • Duque-Afonso, Jesus;
    • Eisenblaetter, Michel;
    • Erbes, Thalia;
    • Fritsch, Ralph;
    • Ge, Isabell Xiang;
    • Geißler, Anna-Lena;
    • Grabbert, Markus
    Publication type:
    Article
    16

    FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN).

    Published in:
    Annals of Hematology, 2024, v. 103, n. 8, p. 2775, doi. 10.1007/s00277-024-05867-w
    By:
    • Isfort, Susanne;
    • von Bubnoff, Nikolas;
    • Al-Ali, Haifa Kathrin;
    • Becker, Heiko;
    • Götze, Thorsten;
    • le Coutre, Philipp;
    • Griesshammer, Martin;
    • Moskwa, Claudia;
    • Wohn, Luisa;
    • Riedel, Johanna;
    • Palandri, Francesca;
    • Manz, Kirsi;
    • Hochhaus, Andreas;
    • Döhner, Konstanze;
    • Heidel, Florian H.
    Publication type:
    Article
    17
    18

    Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.

    Published in:
    2018
    By:
    • Baron, Frédéric;
    • Lefrere, Francois;
    • Sica, Simona;
    • Venditti, Adriano;
    • Amadori, Sergio;
    • Hagemeijer, Anne;
    • Becker, Heiko;
    • Stevens-Kroef, Marian;
    • Muus, Petra;
    • Jansen, Joop H.;
    • de Witte, Theo;
    • Kicinski, Michal;
    • Suciu, Stefan;
    • Meloni, Giovanna;
    • Mancini, Marco;
    • Marie, Jean-Pierre;
    • Halkes, Constantijn J. M.;
    • Willemze, Roelof;
    • Thomas, Xavier;
    • Vrhovac, Radovan
    Publication type:
    journal article
    19

    Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.

    Published in:
    2016
    By:
    • Lübbert, Michael;
    • Suciu, Stefan;
    • Hagemeijer, Anne;
    • Rüter, Björn;
    • Platzbecker, Uwe;
    • Giagounidis, Aristoteles;
    • Selleslag, Dominik;
    • Labar, Boris;
    • Germing, Ulrich;
    • Salih, Helmut;
    • Muus, Petra;
    • Pflüger, Karl-Heinz;
    • Schaefer, Hans-Eckart;
    • Bogatyreva, Lioudmila;
    • Aul, Carlo;
    • Witte, Theo;
    • Ganser, Arnold;
    • Becker, Heiko;
    • Huls, Gerwin;
    • Helm, Lieke
    Publication type:
    journal article
    20

    Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).

    Published in:
    2015
    By:
    • Becker, Heiko;
    • Suciu, Stefan;
    • Rüter, Björn;
    • Platzbecker, Uwe;
    • Giagounidis, Aristoteles;
    • Selleslag, Dominik;
    • Labar, Boris;
    • Germing, Ulrich;
    • Salih, Helmut;
    • Muus, Petra;
    • Pflüger, Karl-Heinz;
    • Hagemeijer, Anne;
    • Schaefer, Hans-Eckart;
    • Fiaccadori, Valeria;
    • Baron, Frédéric;
    • Ganser, Arnold;
    • Aul, Carlo;
    • Witte, Theo;
    • Wijermans, Pierre;
    • Lübbert, Michael
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    New editorial office.

    Published in:
    2005
    By:
    • Becker, Heiko C.;
    • Möllers, Christian;
    • Melchinger, Albrecht;
    • Bauer, Eva;
    • Reif, Jochen
    Publication type:
    Editorial
    48
    49

    Blastic transformation of BCR‐ABL1 positive chronic myeloid leukaemia through acquisition of CBFB‐MYH11 and mutant KIT.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 6, p. e339, doi. 10.1111/bjh.16904
    By:
    • Shoumariyeh, Khalid;
    • Hussung, Saskia;
    • Niemöller, Christoph;
    • Bleul, Sabine;
    • Veratti, Pia;
    • Follo, Marie;
    • Riba, Julian;
    • Philipp, Ulrike;
    • Palmer, Juliane M.;
    • Pfeifer, Dietmar;
    • Pantic, Milena;
    • Meggendorfer, Manja;
    • Hackanson, Björn;
    • Finke, Jürgen;
    • Haferlach, Torsten;
    • Duyster, Justus;
    • Miething, Cornelius;
    • Becker, Heiko;
    • Bubnoff, Nikolas
    Publication type:
    Article
    50

    Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial).

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 2, p. 235, doi. 10.1111/bjh.15546
    By:
    • Krauter, Jürgen;
    • Fiedler, Walter;
    • Schlenk, Richard F.;
    • Paschka, Peter;
    • Thol, Felicitas;
    • Lübbert, Michael;
    • Wattad, Mohammed;
    • Verbeek, Mareike;
    • Könecke, Christian;
    • Neuhaus, Barbara;
    • Papkalla, Armin;
    • Kebenko, Maxim;
    • Janning, Melanie;
    • Döhner, Konstanze;
    • Gaidzik, Verena I.;
    • Becker, Heiko;
    • Greil, Christine;
    • Reimer, Peter;
    • Götze, Katharina S.;
    • Döhner, Hartmut
    Publication type:
    Article